Genetic, behavioral, and sociodemographic risk factors for second eye progression in age-related macular degeneration.
暂无分享,去创建一个
B. J. Klevering | C. Hoyng | S. Fauser | G. J. van der Wilt | C. Boon | Johannes P. H. van de Ven | D. Smailhodzic | J. Groenewoud | A. D. Hollander | Y. Lechanteur
[1] Richard Wormald,et al. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. , 2012, Ophthalmology.
[2] J. Ordovás,et al. Evaluation of new and established age-related macular degeneration susceptibility genes in the Women's Health Initiative Sight Exam (WHI-SE) Study. , 2011, American journal of ophthalmology.
[3] L. Fan,et al. Toll‐like receptor 3 C1234T may protect against geographic atrophy through decreased dsRNA binding capacity , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] K. Nakashima,et al. [The Rotterdam study]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.
[5] Glenn J Jaffe,et al. Reticular drusen associated with geographic atrophy in age-related macular degeneration. , 2011, Investigative ophthalmology & visual science.
[6] Bernd Kirchhof,et al. Evaluation of serum lipid concentrations and genetic variants at high-density lipoprotein metabolism loci and TIMP3 in age-related macular degeneration. , 2011, Investigative ophthalmology & visual science.
[7] H. Chin,et al. LOC387715/HTRA1 polymorphisms, smoking and combined effects on exudative age‐related macular degeneration in a Korean population , 2010, Clinical & experimental ophthalmology.
[8] M. Brantley,et al. The effect of genetic variants in SERPING1 on the risk of neovascular age-related macular degeneration , 2010, British Journal of Ophthalmology.
[9] Margaret A. Pericak-Vance,et al. Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration , 2010, Proceedings of the National Academy of Sciences.
[10] Aaron Y. Lee,et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC) , 2010, Proceedings of the National Academy of Sciences.
[11] H. Meng,et al. SELF‐REPORTED VERSUS MEASURED HEIGHT AND WEIGHT IN THE HEALTH AND RETIREMENT STUDY , 2010, Journal of the American Geriatrics Society.
[12] Dean Y. Li,et al. Genetic and Functional Dissection of HTRA1 and LOC387715 in Age-Related Macular Degeneration , 2010, PLoS genetics.
[13] Sharon D. Solomon,et al. RISK FACTORS FOR SECOND EYE PROGRESSION TO ADVANCED AGE-RELATED MACULAR DEGENERATION: SST Report No. 21 Submacular Surgery Trials Research Group , 2009, Retina.
[14] T. Meitinger,et al. Age‐related macular degeneration and functional promoter and coding variants of the apolipoprotein E gene , 2009, Human mutation.
[15] B. Fridley,et al. Complement component 3 (C3) haplotypes and risk of advanced age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.
[16] M. Daly,et al. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. , 2009, Investigative ophthalmology & visual science.
[17] B. J. Klevering,et al. The spectrum of phenotypes caused by variants in the CFH gene. , 2009, Molecular immunology.
[18] C. Klaver,et al. Complement component C3 and risk of age-related macular degeneration. , 2009, Ophthalmology.
[19] S. Ennis,et al. Association between the SERPING1 gene and age-related macular degeneration: a two-stage case–control study , 2008, The Lancet.
[20] J. Ott,et al. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss , 2008, Journal of Medical Genetics.
[21] G. Parmigiani,et al. Toll-like receptor 3 and geographic atrophy in age-related macular degeneration. , 2008, The New England journal of medicine.
[22] S. Fisher,et al. Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA , 2008, Nature Genetics.
[23] M. Tremblay,et al. Estimates of obesity based on self-report versus direct measures. , 2008, Health reports.
[24] Johanna M Seddon,et al. Variation in complement factor 3 is associated with risk of age-related macular degeneration , 2007, Nature Genetics.
[25] Sharon D. Solomon,et al. Incident choroidal neovascularization in fellow eyes of patients with unilateral subfoveal choroidal neovascularization secondary to age-related macular degeneration: SST report No. 20 from the Submacular Surgery Trials Research Group. , 2007, A M A Archives of Ophthalmology.
[26] P. Bora,et al. The role of complement system in ocular diseases including uveitis and macular degeneration. , 2007, Molecular immunology.
[27] J. Haines,et al. Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. , 2007, Human molecular genetics.
[28] I. Deary,et al. Complement C3 variant and the risk of age-related macular degeneration. , 2007, The New England journal of medicine.
[29] G. Abecasis,et al. Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits. , 2007, Human molecular genetics.
[30] B. Rosner,et al. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. , 2007, JAMA.
[31] Ammarin Thakkinstian,et al. Systematic review and meta-analysis of the association between complementary factor H Y402H polymorphisms and age-related macular degeneration , 2006 .
[32] Yun Li,et al. CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration , 2006, Nature Genetics.
[33] Johanna M Seddon,et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration , 2006, Nature Genetics.
[34] R. T. Smith,et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.
[35] S. Fisher,et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk , 2005 .
[36] F. Holz,et al. Y402H-Polymorphismus im Komplementfaktor H und altersabhängige Makuladegeneration (AMD) , 2005, Der Ophthalmologe.
[37] J. Gilbert,et al. Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.
[38] J. Ott,et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.
[39] Robyn H Guymer,et al. The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. , 2004, Investigative ophthalmology & visual science.
[40] Johanna M Seddon,et al. Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. , 2003, Archives of ophthalmology.
[41] A. Ho,et al. RISK FACTORS FOR CHOROIDAL NEOVASCULARIZATION AND VISION LOSS IN THE FELLOW EYE STUDY OF CNVPT , 2003, Retina.
[42] Johanna M Seddon,et al. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. , 2003, Ophthalmology.
[43] T. Weaver,et al. Miniaturized sealed‐tube allele‐specific PCR , 2002, Human mutation.
[44] S. Nitzke,et al. Self-reported versus measured weight and height in an older adult meal program population. , 1998, The journals of gerontology. Series A, Biological sciences and medical sciences.
[45] C. Duijn,et al. Genetic association of apolipoprotein E with age-related macular degeneration. , 1998, American journal of human genetics.
[46] I. Shami. Smoking and age-related maculopathy , 1997 .
[47] A. Hofman,et al. Age-related macular degeneration and smoking. The Rotterdam Study. , 1996 .
[48] P T de Jong,et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration , 1995 .
[49] R. Klein,et al. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. , 1992, Ophthalmology.
[50] S. Ennis,et al. Support for the involvement of complement factor I in age-related macular degeneration , 2010, European Journal of Human Genetics.
[51] M. Daly,et al. Variation near complement factor I is associated with risk of advanced AMD , 2009, European Journal of Human Genetics.
[52] R. Kuczmarski,et al. Effects of age on validity of self-reported height, weight, and body mass index: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. , 2001, Journal of the American Dietetic Association.
[53] Judith Alexander,et al. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study Group. , 1997, Archives of ophthalmology.
[54] P. Mitchell,et al. Smoking and age-related maculopathy. The Blue Mountains Eye Study. , 1996, Archives of ophthalmology.
[55] R. Klein,et al. The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. , 1992, Ophthalmology.